Non-alcoholic steatohepatitis registry platform study

Trial Identifier: D1843R00356
Sponsor: AstraZeneca
NCTID:: NCT06123858
Start Date: November 2023
Primary Completion Date: December 2026
Study Completion Date: December 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China Beijing, China
China Binzhou, China
China Changchun, China
China Chengdu, China
China Fuzhou, China
China Guangzhou, China
China Hangzhou, China
China Inner Mongolia, China
China Nanchang, China
China Qingdao, China
China Shanghai, China
China Shenyang, China
China Taiyuan, China
China Tianjin, China
China Wenzhou, China
China Xi'an, China
China Xuzhou, China
China Zhengzhou, China